A paired tissue study of 11 patients finds that microRNA patterns tied to apoptosis and fibrosis remain largely unchanged ...
Clinical Trials Arena on MSN
Alnylam reports preliminary Phase Ib trial results for brezosiran
The trial is designed to assess intrathecal doses of brezosiran in adults aged 25 to 70 years with genetically confirmed HD.
Chronic intracerebroventricular neuropeptide S treatment increased NREM sleep and reduced amyloid-related pathology in ...
Responses were deep and durable, with 65% ongoing at clinical cutoff; Results support continued evaluation of the ...
Five participants received SGT-212 in the Phase 1b FALCON trial; initial data are expected in Q1 2027. FDA granted three ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results